Image 1 of 1
CJC-1295 with DAC 5 mg – Growth Hormone Signalling | Extended-Activity Research | Premium Research Compound
A premium research compound supplied in a convenient 5 mg vial.
CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone, commonly abbreviated as GHRH. It is studied for its interaction with growth hormone signalling, endocrine activity, cellular repair processes, and extended peptide stability.
What’s Included
1x CJC-1295 with DAC 5 mg vial
Over 99% Purity
Premium-quality research compound
Shipped from the Gold Coast, Queensland
Australia Post Express Post
Why Choose CJC-1295 with DAC 5 mg?
CJC-1295 with DAC is investigated for its ability to interact with GHRH receptors and influence growth hormone-related signalling pathways.
The Drug Affinity Complex (DAC) is designed to bind with albumin, giving the compound a longer active research profile than shorter-acting GHRH analogues.
This makes it an important compound for researchers studying:
Growth hormone release mechanisms
GHRH receptor activity
IGF-1-related signalling
Extended peptide stability
Endocrine system interactions
Cellular repair and regeneration pathways
CJC-1295 with DAC Research
CJC-1295 with DAC is commonly investigated in relation to:
Growth hormone-related signalling
GHRH receptor activation
IGF-1-associated biological pathways
Protein synthesis mechanisms
Cellular recovery and tissue-repair processes
Metabolic and body-composition pathways
Extended-duration peptide activity
Neuroendocrine signalling
Research continues into how its extended-activity design influences growth hormone pulses, downstream signalling, and other endocrine processes.
Premium Research Compound. One Easy Order.
OZZ Peptides CJC-1295 with DAC 5 mg provides researchers with a convenient option for investigating extended-duration GHRH and growth hormone-related pathways.
Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.
Product Highlights
🧬 GHRH Analogue
Studied for its interaction with growth hormone-releasing hormone receptors.
⏱️ Extended-Activity Design
The Drug Affinity Complex is designed to support greater stability and a longer research profile.
🔬 Growth Hormone Pathway Research
Investigated in connection with growth hormone and IGF-1-related signalling.
⚡ Endocrine Research
Used in research examining hormonal communication, metabolic activity, and cellular processes.
💎 Over 99% Purity
Premium-quality research compound.
📦 Fast Australian Delivery
Sent using Australia Post Express Post.
🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.
What You’ll Receive
1x CJC-1295 with DAC 5 mg vial
Securely packed for delivery
Australia Post Express Post
Storage
Store according to the storage information supplied with the product.
Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required depending on the research protocol.
Important Information
Products supplied by OZZ Peptides are intended for research purposes only and are not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease.
A premium research compound supplied in a convenient 5 mg vial.
CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone, commonly abbreviated as GHRH. It is studied for its interaction with growth hormone signalling, endocrine activity, cellular repair processes, and extended peptide stability.
What’s Included
1x CJC-1295 with DAC 5 mg vial
Over 99% Purity
Premium-quality research compound
Shipped from the Gold Coast, Queensland
Australia Post Express Post
Why Choose CJC-1295 with DAC 5 mg?
CJC-1295 with DAC is investigated for its ability to interact with GHRH receptors and influence growth hormone-related signalling pathways.
The Drug Affinity Complex (DAC) is designed to bind with albumin, giving the compound a longer active research profile than shorter-acting GHRH analogues.
This makes it an important compound for researchers studying:
Growth hormone release mechanisms
GHRH receptor activity
IGF-1-related signalling
Extended peptide stability
Endocrine system interactions
Cellular repair and regeneration pathways
CJC-1295 with DAC Research
CJC-1295 with DAC is commonly investigated in relation to:
Growth hormone-related signalling
GHRH receptor activation
IGF-1-associated biological pathways
Protein synthesis mechanisms
Cellular recovery and tissue-repair processes
Metabolic and body-composition pathways
Extended-duration peptide activity
Neuroendocrine signalling
Research continues into how its extended-activity design influences growth hormone pulses, downstream signalling, and other endocrine processes.
Premium Research Compound. One Easy Order.
OZZ Peptides CJC-1295 with DAC 5 mg provides researchers with a convenient option for investigating extended-duration GHRH and growth hormone-related pathways.
Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.
Product Highlights
🧬 GHRH Analogue
Studied for its interaction with growth hormone-releasing hormone receptors.
⏱️ Extended-Activity Design
The Drug Affinity Complex is designed to support greater stability and a longer research profile.
🔬 Growth Hormone Pathway Research
Investigated in connection with growth hormone and IGF-1-related signalling.
⚡ Endocrine Research
Used in research examining hormonal communication, metabolic activity, and cellular processes.
💎 Over 99% Purity
Premium-quality research compound.
📦 Fast Australian Delivery
Sent using Australia Post Express Post.
🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.
What You’ll Receive
1x CJC-1295 with DAC 5 mg vial
Securely packed for delivery
Australia Post Express Post
Storage
Store according to the storage information supplied with the product.
Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required depending on the research protocol.
Important Information
Products supplied by OZZ Peptides are intended for research purposes only and are not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease.

